ArticlePloS one2016

Anti-Drug Antibodies, Drug Levels, Interleukin-6 and Soluble TNF Receptors in Rheumatoid Arthritis Patients during the First 6 Months of Treatment with Adalimumab or Infliximab: A Descriptive Cohort Study.

Grith Petersen Eng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.